Cawachi Limited

Tokyo Stock Exchange 2664.T

Cawachi Limited EPS (Diluted) for the year ending March 31, 2024: USD 1.39

Cawachi Limited EPS (Diluted) is USD 1.39 for the year ending March 31, 2024, a -0.96% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Cawachi Limited EPS (Diluted) for the year ending March 31, 2023 was USD 1.41, a -20.77% change year over year.
Cawachi Limited EPS (Diluted) for the year ending March 31, 2022 was USD 1.77, a -38.29% change year over year.
Cawachi Limited EPS (Diluted) for the year ending March 31, 2021 was USD 2.88, a 81.69% change year over year.
Cawachi Limited EPS (Diluted) for the year ending March 31, 2020 was USD 1.58, a 98.58% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Tokyo Stock Exchange: 2664.T

Cawachi Limited

CEO	Mr. Shinji Kawachi
IPO Date	Dec. 4, 2002
Location	Japan
Headquarters	1293 Soshima
Employees	2,722
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Specialty Retail

Description

Cawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, health foods, childcare products, cosmetics, daily miscellaneous goods, general food products, confectionery products, etc. It also involved in the insurance business. The company operates 355 drugstores. Cawachi Limited was founded in 1967 and is headquartered in Oyama, Japan.

Key trends

Past 5 years